Добірка наукової літератури з теми "Cardiac a"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cardiac a".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cardiac a"
Rodríguez, Javier, Signed Prieto, Milena Flórez, Claudia Alarcón, Ruth López, Gydnea Aguirre, Laura Pinilla, Omar Rovira, and Laura Méndez. "Cardiac dynamic systems in normal neonates: Neonate chaotic cardiac law." Salud Uninorte 30, no. 3 (December 15, 2014): 361–70. http://dx.doi.org/10.14482/sun.30.3.5757.
Повний текст джерелаÁlvaro Vázquez Lopez-Cepero, Javier Iborra Escalona, and Vicente Torres-Pedrós. "Dispositivos de asistencia mecánica circulatoria." Revista Electrónica AnestesiaR 10, no. 8 (August 31, 2018): 3. http://dx.doi.org/10.30445/rear.v10i8.630.
Повний текст джерелаDebbal, Sidi. "Cardiac Severity Analysis." Journal of Thoracic Disease and Cardiothoracic Surgery 2, no. 2 (August 11, 2021): 01–09. http://dx.doi.org/10.31579/2693-2156/023.
Повний текст джерелаHashmi, Faiz, and Nikita Sharma. "Cardiac Nuclear Medicine." International Journal of Trend in Scientific Research and Development Volume-2, Issue-1 (December 31, 2017): 1235–42. http://dx.doi.org/10.31142/ijtsrd8212.
Повний текст джерелаKisan, Chopade Dnyandeo, Parate Swapna, Gangane Suresh, and Chopade Sandesh. "Cytogenetic Association of Cardiac and Non-Cardiac Anomalies in Down’s Syndrome." Indian Journal of Genetics and Molecular Research 7, no. 1 (2018): 5–11. http://dx.doi.org/10.21088/ijgmr.2319.4782.7118.1.
Повний текст джерелаEun, Sung-Jong, and Jin-Sun Kook. "Evaluation of Cardiac Ejection Fraction using Cardiac MRI." Journal of the Korean Society of Radiology 5, no. 5 (October 31, 2011): 289–94. http://dx.doi.org/10.7742/jksr.2011.5.5.289.
Повний текст джерелаPatil, Amarjeet D., Sunita A. Patil, Vijay Bhola, Supriya Gokhale Gokhale, and Charu Sudan Sudan. "SUCCINYLCHOLINE CAUSING CARDIAC ARREST." Asian Pacific Journal of Health Sciences 1, no. 2 (April 2014): 69–71. http://dx.doi.org/10.21276/apjhs.2014.1.2.6.
Повний текст джерелаPrasad, Arun, Sanjeev Kumar, Pradeep Kumar, Manju Kumari, and Rajesh Kumar. "Cardiac Rhabdomyoma in Children." Indian Journal of Trauma and Emergency Pediatrics 10, no. 2 (2018): 49–51. http://dx.doi.org/10.21088/ijtep.2348.9987.10218.3.
Повний текст джерелаJacome Ruiz, Pablo, and Christian Baquerizo Cardenas. "Monitor Cardíaco Portátil con Interfaz Bluetooth “CARDIO UEES” / Portable Heart Monitor with a Bluetooth Interface “CARDIO UEES”." Ciencia Unemi 9, no. 20 (December 20, 2016): 36. http://dx.doi.org/10.29076/issn.2528-7737vol9iss20.2016pp36-49p.
Повний текст джерелаGeddes, L. A. "Fibrilacion — Defibrilacion cardiaca (Cardiac fibrillation and defibrillation)." Journal of Biomedical Engineering 9, no. 4 (October 1987): 379–81. http://dx.doi.org/10.1016/0141-5425(87)90089-6.
Повний текст джерелаДисертації з теми "Cardiac a"
McDonald, Cameron. "Investigations in Cardiac Development and Cardiac Regeneration." Thesis, Griffith University, 2009. http://hdl.handle.net/10072/366063.
Повний текст джерелаThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Biomolecular and Physical Sciences
Science, Environment, Engineering and Technology
Full Text
Paul, Ashok Abraham. "Investigation of cardiac and non-cardiac drugs that modulate cardiac Herg K⺠channels." Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274632.
Повний текст джерелаBaily, James Edward. "Role of cardiac perivascular cells in cardiac repair." Thesis, University of Edinburgh, 2015. http://hdl.handle.net/1842/15846.
Повний текст джерелаGràcia, Sánchez Laura Maria. "Tomografía por emisión de positrones con 18F-FDG en patología cardíaca y vascular." Doctoral thesis, Universitat Autònoma de Barcelona, 2016. http://hdl.handle.net/10803/399846.
Повний текст джерела18F-FDG PET/CT is a valuable diagnostic tool in the evaluation of inflammatory and infection diseases. Appropriate patient preparation is important because the diagnostic accuracy of this procedure depends on an adequate suppression of physiologic glucose uptake in the myocardium. There are different methods to reduce myocardial 18F-FDG uptake, such as long fasting period, high fat and low-carbohydrate diet and the administration of heparin some minutes before the 18F-FDG dose injection only if there is no counter-indication Due to their pathological background or their individual characteristics, many patients are unable to do fast for many hours or to follow high fat and low-carbohydrate diet before the scan. The administration of heparin some minutes before the 18F-FDG dose injection is the only method to try to do an adequate suppression of physiologic glucose uptake in the myocardium. However, not always the heparin’s method works properly doing a suppression of physiologic glucose uptake in the myocardium. The aim of this project is to try to know when the heparin is going to be effective, depending on the pathological background of patients, chronic treatment and individual characteristics. Therefore, if it is known in which subjects is not going to be effective we could avoid treating them. 479 subjects were evaluated (230 women), mean age 65 years old (22-86) with indication of 18F-FDG PET/CT due to an oncological illness, or infection or inflammatory suspect of a cardiac or vascular process. Five groups of subjects were studied: Subjects with diabetes mellitus, subjects with dyslipidemia under chronic lipid lowering therapy, subjects with dyslipidemia but without chronic treatment for dyslipidemia, subjects with metabolic syndrome (diabetes and dyslipidemia coexistence) and the last group of normal subjects, without diabetes nor dyslipidemia. We compare two methods. One is based on at least 6 hours of fasting and the second one is based on at least 6 hours of fasting plus the administration of heparin some minutes before the 18F-FDG dose injection. We compare the suppression of physiologic glucose uptake in the myocardium in the different groups of study with both methodologies. The heparin method obtains more suppression of physiologic glucose uptake in the myocardium, with statistically significant results in all the global population and in the group with dyslipidemia but without chronic treatment for dyslipidemia. The heparin method obtains a bigger number of subjects but with no statistically significant results in the normal group and in the metabolic syndrome group. In these groups we should perform regularly the heparin methodology searching for an adequate suppression of physiologic glucose uptake in the myocardium. In contrast to those results, we observe that the heparin method is not useful with almost statistically significant results in the diabetes mellitus group, and in the group with dyslipidemia under chronic lipid lowering therapy. In these groups we should only perform long fasting period methodology. After the results obtained in this project we have confirmed the utility of heparin administration in our community, and the best way to use it with the appropriate subjects, depending on their pathological background, chronic treatment and individual characteristics.
Burford, Evans J. "Myocyte Derived Cardiac Spheroids for Post Infarct Cardiac Regeneration." Digital WPI, 2014. https://digitalcommons.wpi.edu/etd-theses/145.
Повний текст джерелаStirparo, G. G. "DEFINITION OF TRANSCRIPTIONAL LANDSCAPE IN CARDIAC MATURATION AND CARDIAC HYPERTROPHY." Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/247064.
Повний текст джерелаVeiga, Viviane Cordeiro 1976. "Avaliação ecocardiografica da terapia de ressincronização cardiaca : dois anos de seguimento." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311904.
Повний текст джерелаDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-12T15:05:14Z (GMT). No. of bitstreams: 1 Veiga_VivianeCordeiro_M.pdf: 4383215 bytes, checksum: 4ac235c87c9173ad91395fd7c6466208 (MD5) Previous issue date: 2008
Resumo: Introdução A terapia de ressincronização cardíaca é uma opção efetiva nos pacientes com insuficiência cardíaca avançada. No entanto, 20 a 30% dos pacientes não apresentam benefícios à esta terapêutica. Critérios clínicos, eletrocardiográficos e ecocardiográficos têm sido estudados na tentativa de selecionar os pacientes que serão beneficiados com a ressincronização cardíaca, sendo o ecocardiograma um método utilizado tanto na seleção, quanto na avaliação e otimização desta terapêutica. Objetivo: O objetivo deste trabalho é analisar a utilização do ecocardiograma na avaliação da terapia de ressincronização cardíaca em pacientes portadores de insuficiência cardíaca refratária, no seguimento a curto prazo (dez dias) e após dois anos de evolução. Casuística e Método: Foram avaliados 20 pacientes com indicação de implante de marcapasso biventricular para terapia de ressincronização cardíaca no período de dois anos, sendo 16 (80%) do sexo masculino, com idade variando de 27 a 80 anos (59,70 ± 12,59 anos). A etiologia da cardiomiopatia era isquêmica em 10 pacientes (50%), chagásica em seis (30%) e idiopática em 4 (20%). Quinze pacientes encontravam-se em classe funcional III (New York Heart Association) e cinco em classe funcional IV no momento do implante do marcapasso. Foi aplicado o Questionário de Qualidade de Vida de Minnesota e realizado o teste de caminhada de seis minutos para avaliação das condições clínicas dos pacientes. Realizado ecodopplercardiograma bidimensional para avaliação da função ventricular, diâmetros cavitários, índice de performance miocárdica, estudo da dissincronia interventricular (avaliação do atraso eletromecânico entre os ventrículos esquerdo e direito) e intraventricular (análise pelo modo unidimensional e Doppler tecidual), da função diastólica e do grau da regurgitação mitral. Dez dias após o implante do marcapasso biventricular, foi repetida toda a avaliação inicial e, novamente, após dois anos. Resultados: Em dois anos, cinco pacientes (25%) foram à óbito, sendo que destes, quatro apresentavam etiologia chagásica. A duração média do complexo QRS era de 154,5±18,48 x 129,0±22,91 x 134,0±24,14 ms, respectivamente nos períodos pré-operatório, dez dias e dois anos de pós-operatório. Não houve alteração estatisticamente significante da fração de ejeção entre os períodos pré-operatório e dez dias, mas houve alteração significante entre os períodos pré-operatório e dois anos e dez dias e dois anos. No seguimento de dez dias, houve piora da dissincronia intraventricular avaliada pelo Doppler tecidual, assim como a pontuação no escore de qualidade de vida foi maior, no grupo óbito. Conclusão: A ecocardiografia é uma tecnologia em evolução e dos parâmetros avaliados, somente a avaliação da dissincronia intraventricular pelo Doppler tecidual após o procedimento, foi capaz de predizer a eficácia da terapia de ressincronização cardíaca, em relação à mortalidade. Não houve correlação entre os parâmetros ecocardiográficos e a melhora clínica de alguns pacientes.
Abstract: Introduction In the cardiac resynchronization therapy is an effective option for patients with advanced heart failure. However, 20 to 30% of patients did not show benefits to this therapy. Clinical criteria, electrocardiography and the echocardiography have been studied in an attempt to select the patients who will benefit from the cardiac resynchronization, and the echocardiogram is a method used in both the selection, as in the evaluation and optimization of this therapy. Objective: The objective of this study is to evaluate the use of echocardiography in the evaluation of patients undergoing cardiac resynchronization therapy for a period of two years. Patients and Methods: We evaluated 20 patients with the implantation of biventricular pacemaker for cardiac resynchronization therapy for over two years, and 16 (80%) males, ranging in age from 27 to 80 years (59.70±12.59 years). The etiology of cardiomyopathy was ischemic in 10 patients (50%), Chagas disease in six (30%) and idiophatic in 4 (20%). Fifteen patients were in functional class III (New York Heart Association) and five in functional class IV at the time of implantation of the pacemaker. We applied the Quality of Life Questionnaire of Minnesota and conducted the test of a six-minute walk to evaluate the clinical conditions of patients. Directed two-dimensional Doppler echocardiography for evaluation of ventricular function, cavity diameters, myocardial performance index, study of interventricular dyssynchrony (eletromechanical delay left ventricle - the right ventricle) and intraventricular (by way dimensional analysis and tissue Doppler), the diastolic function and degree of mitral regurgitation. Ten days after implantation of biventricular pacemaker, was repeated throughout the initial assessment and again after two years. Results: In two years, five patients (25%) were to death, and that these, four had Chagas disease. The average duration of the QRS complex was 154.5±18.48 x 129.0±22.91 x 134.0±24.14 ms, respectively in preoperative, ten days and two years after surgery. There was no statistically significant change in the ejection fraction between preoperative and ten days but there was significant change between periods preoperative and 2 years and 10 days and 2 years. Following ten days, the evaluation of intraventricular dyssynchrony by tissue Doppler and quality of life scores were significantly higher in the group died. Conclusion: The echocardiography is an evolving technology and the parameters evaluated, only the assessment of intraventricular dyssynchrony by Doppler tissue after the procedure was able to predict the effectiveness of the cardiac resynchronization therapy, in relation to mortality. There was no correlation between echocardiographic parameters and clinical improvement in some patients.
Mestrado
Mestre em Cirurgia
Dawson, Jennifer Elizabeth. "Cardiac Tissue Engineering." Thèse, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20071.
Повний текст джерелаPeace, Richard Aidan. "Quantitative cardiac SPECT." Thesis, University of Aberdeen, 2001. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU602292.
Повний текст джерелаSemenas, Egidijus. "Sex Differences in Cardiac and Cerebral Damage after Hypovolemic Cardiac Arrest." Doctoral thesis, Uppsala universitet, Anestesiologi och intensivvård, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-146314.
Повний текст джерелаКниги з теми "Cardiac a"
E, Josephson Mark, ed. Sudden cardiac death. Boston: Blackwell Scientific Publications, 1994.
Знайти повний текст джерелаSolti, Ferenc. Cardiac lymph circulation and cardiac disorders. Budapest: Akadémiai Kiadó, 1989.
Знайти повний текст джерелаGussak, Ihor, Charles Antzelevitch, Stephen C. Hammill, Win K. Shen, and Preben Bjerregaard. Cardiac Repolarization. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592593623.
Повний текст джерелаWu, Alan H. B. Cardiac Markers. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592593852.
Повний текст джерелаCardiac surgery. St. Louis: Mosby, 1994.
Знайти повний текст джерелаParikh, Milind G. Cardiac Electrophysiology. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-75326-9.
Повний текст джерелаJugdutt, Bodh I., and Naranjan S. Dhalla, eds. Cardiac Remodeling. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-5930-9.
Повний текст джерелаOstadal, Bohuslav, and Naranjan S. Dhalla, eds. Cardiac Adaptations. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-5203-4.
Повний текст джерелаSuvarna, S. Kim, ed. Cardiac Pathology. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-24560-3.
Повний текст джерелаPoss, Kenneth D., and Bernhard Kühn, eds. Cardiac Regeneration. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-0668-1.
Повний текст джерелаЧастини книг з теми "Cardiac a"
Gallacher, David J., Gary Gintant, Najah Abi-Gerges, Mark R. Davies, Hua Rong Lu, Kimberly M. Hoagland, Georg Rast, Brian D. Guth, Hugo M. Vargas, and Robert L. Hamlin. "Cardiac." In Drug Discovery Toxicology, 130–59. Hoboken, NJ: John Wiley & Sons, Inc, 2016. http://dx.doi.org/10.1002/9781119053248.ch9.
Повний текст джерелаHan, Dan, Bo He, and Li Wu. "Cardiac." In Dual Source CT Imaging, 47–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_3.
Повний текст джерелаMing, Liu, Feng Yun, Xue Jianping, and Li Yuhua. "Cardiac." In Dual Source CT Imaging, 55–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_4.
Повний текст джерелаLan, Song, Wang Yining, Zhang Zhuhua, Kong Lingyan, and Jin Zhengyu. "Cardiac." In Dual Source CT Imaging, 63–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_5.
Повний текст джерелаKang, Joon-Won, Joon Beom Seo, Kyung-Hyun Do, and Tae-Hwan Lim. "Cardiac." In Dual Source CT Imaging, 71–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_6.
Повний текст джерелаCheah, Foong Koon, and John Huang. "Cardiac." In Dual Source CT Imaging, 79–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_7.
Повний текст джерелаLan, Song, Wang Yining, Zhang Zhuhua, Kong Lingyan, and Jin Zhengyu. "Cardiac." In Dual Source CT Imaging, 87–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_8.
Повний текст джерелаJin, Gongyong, Youngkon Kim, and Hyosung Kwak. "Cardiac." In Dual Source CT Imaging, 95–101. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-15134-7_9.
Повний текст джерелаImam, Ibrahim. "Cardiac." In 700 Essential Neurology Checklists, 390–91. New York: CRC Press, 2021. http://dx.doi.org/10.1201/9781003221258-122.
Повний текст джерелаForman, Daniel E. "Cardiac Rehabilitation for Elderly Cardiac Patients." In Cardiac Rehabilitation, 243–51. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-452-0_21.
Повний текст джерелаТези доповідей конференцій з теми "Cardiac a"
"Clinical: Cardiac." In Proceedings of UK Radiological Conference 2012. The British Institute of Radiology, 2012. http://dx.doi.org/10.1259/conf-pukrc.2012.2.cardiac.
Повний текст джерела"Clinical: Cardiac." In Proceedings of UK Radiological Conference 2013. The British Institute of Radiology, 2013. http://dx.doi.org/10.1259/conf-pukrc.2013.cardiac.
Повний текст джерелаAbilez, O. J. "Cardiac optogenetics." In 2012 34th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2012. http://dx.doi.org/10.1109/embc.2012.6346197.
Повний текст джерелаLin, Feng, Chen Song, Yan Zhuang, Wenyao Xu, Changzhi Li, and Kui Ren. "Cardiac Scan." In MobiCom '17: The 23rd Annual International Conference on Mobile Computing and Networking. New York, NY, USA: ACM, 2017. http://dx.doi.org/10.1145/3117811.3117839.
Повний текст джерелаVejseli, Veton, and Eun Jung Lee. "Cardiac Fibroblast-Formed Anisotropic Decellularized Engineered Cardiac Tissues." In 2013 39th Annual Northeast Bioengineering Conference (NEBEC). IEEE, 2013. http://dx.doi.org/10.1109/nebec.2013.4.
Повний текст джерелаConnolly, M., A. Fallon, D. Waterhouse, and R. O’Hanlon. "45 Progression of cardiac amyloid fibril infiltration in cardiac amyloidosis using cardiac magnetic resonance." In Irish Cardiac Society Annual Scientific Meeting & AGM, Thursday October 4th – Saturday October 6th 2018, Galway Bay Hotel, Galway, Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-ics.45.
Повний текст джерелаWelk, E., M. Heep, P. Grieshaber, B. Niemann, K. D. Schlüter, and A. Boening. "Levosimendan during Cardiac Surgery Deteriorates Cardiac Function in Rats." In 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678927.
Повний текст джерелаShafuddin, Eskandarain, Catherina Chang, and Robert Hancox. "Cardiac function during COPD exacerbations assessed by cardiac MRI." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.oa1919.
Повний текст джерелаPark, Heejong, Avinash Malik, Muhammad Nadeem, and Zoran Salcic. "The Cardiac Pacemaker." In the 12th International Workshop. New York, New York, USA: ACM Press, 2014. http://dx.doi.org/10.1145/2661020.2661030.
Повний текст джерелаTSALIKAKIS, D. G., G. P. KREMMYDAS, and D. I. FOTIADIS. "MULTIDIMENSIONAL CARDIAC MODELS." In Proceedings of the Seventh International Workshop. WORLD SCIENTIFIC, 2006. http://dx.doi.org/10.1142/9789812773197_0041.
Повний текст джерелаЗвіти організацій з теми "Cardiac a"
Finsterer, Josef. Cardiac and extra-cardiac abnormalities associated with noncompaction. Science Repository OÜ, February 2019. http://dx.doi.org/10.31487/j.rgm.2019.01.002.
Повний текст джерелаVernalis, Marina N., and Audra H. Nixon. Integrative Cardiac Health Project. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada612248.
Повний текст джерелаNickoloff, Edward L., Keith J. Strauss, Bruce T. Austin, Stephen Balter, Geoffrey D. Clarke, Pei-Jan Paul Lin, Marlene H. P. McKetty, et al. Cardiac Catheterization Equipment Performance. AAPM, 2001. http://dx.doi.org/10.37206/69.
Повний текст джерелаBrock, William J., Edgar C. Kimmel, and Warren W. Jederberg. Commentary and Scientific Review of Studies on Cardiac Function and Cardiac Sensitization Models. Fort Belvoir, VA: Defense Technical Information Center, May 2003. http://dx.doi.org/10.21236/ada414064.
Повний текст джерелаGauthier, Gail D. Strategic Planning for Cardiac Services. Fort Belvoir, VA: Defense Technical Information Center, April 2008. http://dx.doi.org/10.21236/ada493528.
Повний текст джерелаZoltani, C. K., G. E. Platoff, and S. I. Baskin. Simulation Studies of Cyanide-Caused Cardiac Toxicity. Fort Belvoir, VA: Defense Technical Information Center, March 2005. http://dx.doi.org/10.21236/ada432856.
Повний текст джерелаEllsworth, Darrell L. Integrative Cardiac Health Project, Windber Research Institute. Fort Belvoir, VA: Defense Technical Information Center, July 2013. http://dx.doi.org/10.21236/ada581897.
Повний текст джерелаKlipp, Robert. Catecholamine Interactions with the Cardiac Ryanodine Receptor. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.1438.
Повний текст джерелаYe, Yanping. Designing New Drugs to Treat Cardiac Arrhythmia. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.638.
Повний текст джерелаEvenson, Kelly R., Ty A. Ridenour, Jacqueline Bagwell, and Robert D. Furberg. Sustaining Physical Activity Following Cardiac Rehabilitation Discharge. RTI Press, February 2021. http://dx.doi.org/10.3768/rtipress.2021.rr.0043.2102.
Повний текст джерела